Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Neuer Gesetzesentwurf!: Kommt nach der Cannabis-Neuregulierung nun eine komplette Legalisierung in USA?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
12 Leser
Artikel bewerten:
(0)

Capita Develops Triage Solution to Support Healthcare Professionals in Fight Against Zika Virus

BASINGSTOKE, England, February 10, 2016 /PRNewswire/ --

Capita Healthcare Decisions has developed a new triage solution to help healthcare providers and professionals assess patients with suspected Zika virus symptoms and enable them to provide the most appropriate advice.

(Logo: http://photos.prnewswire.com/prnh/20150402/736790 )

The Zika virus is currently recognised as a public health emergency of international concern by The World Health Organization*.

The new triage solution will sit within Capita Healthcare Decisions' internationally renowned clinical triage tools, enabling patients, their relatives and clinicians to check symptoms and concerns against clinically validated and robust criteria.

The Zika triage solution is being made available to all of Capita Healthcare Decisions' clients, supporting more than 320m individuals worldwide, including those in the worst affected areas, such as Brazil.

As well as being part of tools which support telephone triage provided by healthcare professionals, the new Zika triage solution will also be available for use directly by patients and carers to check their own symptoms and concerns, or those of someone they are concerned about using Capita Healthcare Decisions' web-based self-triage solution. Supporting patients' self-care in this way avoids medical facilities becoming overwhelmed, and means people potentially infected with the Zika virus can be treated quickly and in the most appropriate way.

Dr Charles Young, chief medical officer at Capita Healthcare Decisions, said: "The agility of our software and our clinical expertise means we can and do react quickly and efficiently to developing healthcare emergencies. Our clinical systems are continually updated to take into account new advice and best practice so clinicians are able to offer the most up-to-date guidance. The aim with this new Zika-focused tool is to enable those who may have symptoms of the Zika virus to receive the most appropriate advice from healthcare professionals, as quickly as possible."

Notes to editors

*http://www.who.int/mediacentre/factsheets/zika/en/

About Capita Healthcare Decisions (formerly Clinical Solutions)

We transform healthcare decision making. Our solutions support healthcare providers to make better decisions about their patients, and empower individuals to make better decisions about their own health and wellbeing. Over the past 15 years, our decision support software applications have been used by some of the world's leading healthcare providers to power over 85m patient transactions. Capita Healthcare Decisions brings together clinical expertise and Silicon Valley innovation to power decision support which delivers more for less and is underpinned by three principles: safe, connected, useful. For more information go to http://www.capita.co.uk/healthcaredecisions

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.